pachastrissamine and pyrrolidine

pachastrissamine has been researched along with pyrrolidine* in 1 studies

Other Studies

1 other study(ies) available for pachastrissamine and pyrrolidine

ArticleYear
Evaluation of pyrrolidine-based analog of jaspine B as potential SphK1 inhibitors against rheumatoid arthritis.
    Bioorganic & medicinal chemistry letters, 2021, 02-15, Volume: 34

    Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovitise, and its pathogenesis is complicated. Sphingosine-1-phosphate (S1P) is a lipid produced by sphingosine kinase 1 and 2 (SphK1/2), which participate in some of most-spread skeletal diseases such as rheumatoid arthritis or osteoarthritis. To explore the anti-inflammatory activity of 2-epi-jaspine B analogs as SphKs inhibitors, we used LPS-induced rheumatoid arthritis fibroblast-like synovial cells (HFLS-RA) as the research object to evaluate the anti-inflammatory activity of 16 2-epi-jaspine B analogs and the newly synthesized salt CHJ01. We found that 2-epi-jaspine B analog CHJ01 in hydrochloride salt form has excellent SphK1 inhibitory effect and better anti-RA effect. CHJ01 showed an anti-inflammatory effect similar to that of MTX in vitro, its IC

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Freund's Adjuvant; Molecular Structure; Phosphotransferases (Alcohol Group Acceptor); Pyrrolidines; Rats; Sphingosine; Structure-Activity Relationship

2021